| Q34439974 | A near-infrared fluorescent voltage-sensitive dye allows for moderate-throughput electrophysiological analyses of human induced pluripotent stem cell-derived cardiomyocytes |
| Q36566235 | A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards |
| Q33961690 | A systemic evaluation of cardiac differentiation from mRNA reprogrammed human induced pluripotent stem cells. |
| Q28547114 | Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC Models |
| Q90380343 | Applications for Induced Pluripotent Stem Cells in Disease Modelling and Drug Development for Heart Diseases |
| Q36683233 | Automated Electrophysiological and Pharmacological Evaluation of Human Pluripotent Stem Cell-Derived Cardiomyocytes |
| Q64248439 | Automated quantification study of human cardiomyocyte synchronization using holographic imaging |
| Q55527693 | Automatic Optimization of an in Silico Model of Human iPSC Derived Cardiomyocytes Recapitulating Calcium Handling Abnormalities. |
| Q39150543 | Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects. |
| Q33164771 | Calcium transients closely reflect prolonged action potentials in iPSC models of inherited cardiac arrhythmia |
| Q39010745 | Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies? |
| Q38393181 | Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes |
| Q38042792 | Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractility |
| Q37573646 | Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform. |
| Q38454536 | Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies |
| Q38671689 | Cardiotoxicity screening: a review of rapid-throughput in vitro approaches. |
| Q26798131 | Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells |
| Q34183137 | Chemical genetics and its potential in cardiac stem cell therapy. |
| Q27021919 | Clinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem Cells |
| Q38755883 | Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications |
| Q55544139 | Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications. |
| Q36861735 | Comparative analysis of targeted differentiation of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells reveals variability associated with incomplete transgene silencing in retrovirally derived hiPSC lines |
| Q44400946 | Computational models of ventricular- and atrial-like human induced pluripotent stem cell derived cardiomyocytes. |
| Q38512145 | Concise Review: Cardiac Disease Modeling Using Induced Pluripotent Stem Cells. |
| Q37680999 | Concise review: drug discovery in the age of the induced pluripotent stem cell |
| Q38077159 | Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes |
| Q30411331 | Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy |
| Q38796118 | Cryopreservation of Human Pluripotent Stem Cell-Derived Cardiomyocytes: Strategies, Challenges, and Future Directions. |
| Q34465393 | Culture conditions affect cardiac differentiation potential of human pluripotent stem cells |
| Q38034129 | Current status of drug screening and disease modelling in human pluripotent stem cells. |
| Q55361234 | Detection of genetic cardiac diseases by Ca2+ transient profiles using machine learning methods. |
| Q36247765 | Development of high content imaging methods for cell death detection in human pluripotent stem cell-derived cardiomyocytes. |
| Q38740489 | Differential Sarcomere and Electrophysiological Maturation of Human iPSC-Derived Cardiac Myocytes in Monolayer vs. Aggregation-Based Differentiation Protocols |
| Q38919220 | Disease modelling using human iPSCs |
| Q39014760 | Distinct electrophysiological and mechanical beating phenotypes of long QT syndrome type 1-specific cardiomyocytes carrying different mutations. |
| Q48183741 | Divergent effect of adrenaline in human induced pluripotent stem cell derived cardiomyocytes obtained from hypertrophic cardiomyopathy |
| Q36632323 | Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes |
| Q36421944 | Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies |
| Q49455393 | Engineered human pluripotent stem cell-derived cardiac cells and tissues for electrophysiological studies |
| Q41980282 | Error-Correcting Output Codes in Classification of Human Induced Pluripotent Stem Cell Colony Images. |
| Q40156224 | Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes |
| Q46086758 | Evaluation of Optogenetic Electrophysiology Tools in Human Stem Cell-Derived Cardiomyocytes |
| Q48293707 | Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes |
| Q41994668 | Functional and pharmacological analysis of cardiomyocytes differentiated from human peripheral blood mononuclear-derived pluripotent stem cells |
| Q36975788 | Gene mutations in cardiac arrhythmias: a review of recent evidence in ion channelopathies. |
| Q27307424 | Generation of highly purified human cardiomyocytes from peripheral blood mononuclear cell-derived induced pluripotent stem cells |
| Q59357914 | Genome Editing of Induced Pluripotent Stem Cells to Decipher Cardiac Channelopathy Variant |
| Q26750618 | Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease Modeling |
| Q89433762 | Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as Models for Cardiac Channelopathies: A Primer for Non-Electrophysiologists |
| Q38947458 | Human derived cardiomyocytes: A decade of knowledge after the discovery of induced pluripotent stem cells |
| Q39345477 | Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes. |
| Q39443185 | Human iPSC-Derived Cardiomyocytes for Investigation of Disease Mechanisms and Therapeutic Strategies in Inherited Arrhythmia Syndromes: Strengths and Limitations. |
| Q39050993 | Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening |
| Q38487497 | Human induced pluripotent stem cell for modeling cardiovascular diseases |
| Q28081697 | Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes |
| Q42606979 | Human induced pluripotent stem cell-derived versus adult cardiomyocytes: an in silico electrophysiological study on effects of ionic current block. |
| Q41664792 | Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies |
| Q41231682 | Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools. |
| Q55499094 | Human-Induced Pluripotent Stem Cell Technology and Cardiomyocyte Generation: Progress and Clinical Applications. |
| Q39173422 | Identification and characterization of a transient outward K+ current in human induced pluripotent stem cell-derived cardiomyocytes. |
| Q38013733 | In vitro uses of human pluripotent stem cell-derived cardiomyocytes. |
| Q38071032 | In-a-dish: induced pluripotent stem cells as a novel model for human diseases |
| Q38700801 | Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications |
| Q57454780 | Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development |
| Q89010083 | Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association |
| Q36254286 | Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias |
| Q36398099 | Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease |
| Q28083057 | Induced pluripotent stem cell potential in medicine, specifically focused on reproductive medicine |
| Q26828408 | Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screening |
| Q26853227 | Induced pluripotent stem cell-derived cardiomyocytes in studies of inherited arrhythmias |
| Q38097414 | Induced pluripotent stem cell-derived cardiomyocytes: boutique science or valuable arrhythmia model? |
| Q38039220 | Induced pluripotent stem cells and their potential for basic and clinical sciences |
| Q38104143 | Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling |
| Q38167806 | Induced pluripotent stem cells as cardiac arrhythmic in vitro models and the impact for drug discovery. |
| Q26781825 | Induced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discovery |
| Q38786687 | Induced pluripotent stem cells: at the heart of cardiovascular precision medicine |
| Q34303709 | Induced pluripotent stem cells: the new patient? |
| Q34431170 | Investigating human disease using stem cell models |
| Q34038853 | Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome |
| Q59808929 | Large-Scale Simulation of the Phenotypical Variability Induced by Loss-of-Function Long QT Mutations in Human Induced Pluripotent Stem Cell Cardiomyocytes |
| Q38938416 | Large-scale mutational analysis of Kv11.1 reveals molecular insights into type 2 long QT syndrome |
| Q64074244 | Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells |
| Q92804016 | Long QT Syndrome: Genetics and Future Perspective |
| Q33830565 | Low extracellular potassium prolongs repolarization and evokes early afterdepolarization in human induced pluripotent stem cell-derived cardiomyocytes |
| Q38834263 | Machine Learning Approach to Automated Quality Identification of Human Induced Pluripotent Stem Cell Colony Images. |
| Q58111146 | Many Cells Make Life Work-Multicellularity in Stem Cell-Based Cardiac Disease Modelling |
| Q38843274 | Maturation of human pluripotent stem cell derived cardiomyocytes is improved in cardiovascular construct. |
| Q27024992 | Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes |
| Q26771911 | Methods for in vitro functional analysis of iPSC derived cardiomyocytes - Special focus on analyzing the mechanical beating behavior |
| Q33704567 | Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
| Q37143372 | Modeling heart disease in a dish: from somatic cells to disease-relevant cardiomyocytes |
| Q27024060 | Modeling inherited cardiac disorders |
| Q38053086 | Modeling long-QT syndromes with iPS cells. |
| Q92816390 | Modeling of LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cells |
| Q47747683 | Modeling rare diseases with induced pluripotent stem cell technology. |
| Q38114432 | Modelling human channelopathies using induced pluripotent stem cells: a comprehensive review |
| Q26864380 | Modelling human disease with pluripotent stem cells |
| Q28255887 | Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes |
| Q27304749 | MultiElec: A MATLAB Based Application for MEA Data Analysis |
| Q27314792 | Mutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or α-Tropomyosin Mutation for Hypertrophic Cardiomyopathy. |
| Q35144310 | N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons |
| Q26779454 | Nanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic Phenotype |
| Q38738993 | Navigating the labyrinth of cardiac regeneration |
| Q37662636 | New and TALENted genome engineering toolbox |
| Q33163663 | New iPSC for old long QT syndrome modeling: putting the evidence into perspective |
| Q50563262 | Nos3-/- iPSCs model concordant signatures of in utero cardiac pathogenesis. |
| Q39615996 | OrganDots--an organotypic 3D tissue culture platform for drug development |
| Q48023580 | Organs-on-Chips with combined multi-electrode array and transepithelial electrical resistance measurement capabilities. |
| Q42205262 | Patch clamp apply in cardiomyocytes derived from patient's iPS cells for individual anticancer therapy. |
| Q37710335 | Patient-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization of Cardiac Cells |
| Q39144910 | Perspectives and Challenges of Pluripotent Stem Cells in Cardiac Arrhythmia Research. |
| Q47109455 | Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: An in silico approach. |
| Q35414785 | Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes |
| Q52560413 | Pluripotent Stem Cell-Derived Cardiomyocytes as a Platform for Cell Therapy Applications: Progress and Hurdles for Clinical Translation. |
| Q42962438 | Pluripotent and somatic stem cells: from basic science to utilization in disease modeling and therapeutic application. Meeting report on the 7th International Meeting of the Stem Cell Network North Rhine Westphalia. |
| Q37256433 | Pluripotent stem cell models of human heart disease |
| Q38235190 | Pluripotent stem cells as a platform for cardiac arrhythmia drug screening |
| Q92834423 | Pneumatic unidirectional cell stretching device for mechanobiological studies of cardiomyocytes |
| Q92519813 | Polyethylene Terephthalate Textiles Enhance the Structural Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
| Q43920140 | Potassium currents in the heart: functional roles in repolarization, arrhythmia and therapeutics |
| Q42231933 | Re-trafficking of hERG reverses long QT syndrome 2 phenotype in human iPS-derived cardiomyocytes. |
| Q37994281 | Reprogramming cellular identity for regenerative medicine |
| Q42427786 | Scalable Electrophysiological Investigation of iPS Cell-Derived Cardiomyocytes Obtained by a Lentiviral Purification Strategy |
| Q47604022 | Simultaneous Measurement of Contraction and Calcium Transients in Stem Cell Derived Cardiomyocytes |
| Q89408767 | Simultaneous recordings of action potentials and calcium transients from human induced pluripotent stem cell derived cardiomyocytes |
| Q64111795 | Stem cell models as an model for predictive toxicology |
| Q28818235 | Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury |
| Q88913236 | The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing |
| Q30828413 | The Effects of Pharmacological Compounds on Beat Rate Variations in Human Long QT-Syndrome Cardiomyocytes |
| Q33748399 | The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications. |
| Q35765543 | The current status of iPS cells in cardiac research and their potential for tissue engineering and regenerative medicine |
| Q33163638 | The disease-specific phenotype in cardiomyocytes derived from induced pluripotent stem cells of two long QT syndrome type 3 patients. |
| Q38107796 | The future of the patient-specific Body-on-a-chip. |
| Q52584821 | The genetic architecture of long QT syndrome: A critical reappraisal. |
| Q37678040 | The genetics of pro-arrhythmic adverse drug reactions. |
| Q36141836 | Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome |
| Q28076397 | Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine |
| Q35141241 | Video image-based analysis of single human induced pluripotent stem cell derived cardiomyocyte beating dynamics using digital image correlation. |
| Q26750663 | Young at Heart: Pioneering Approaches to Model Nonischaemic Cardiomyopathy with Induced Pluripotent Stem Cells |
| Q34431713 | iPCS Cell Modeling of Inherited Cardiac Arrhythmias |
| Q38185513 | iPS cells: a game changer for future medicine |